Completed OBSERVATIONAL NCT01078688

Evaluation of the Frequency of Limitation of Activity in Patients With Persistent Asthma (ASMAVIE)

Evaluation of the Frequency of Limitation of Activity, Depending on Gender and Age-group, in Patients With Persistent Asthma Consulting a General Practitioner

Sponsor: AstraZeneca

Conditions Persistent Asthma

Updated 7 times since 2017 Last updated: Jan 28, 2013 Started: Mar 31, 2010 Primary completion: Oct 31, 2010 Completion: Oct 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01078688, this observational or N/A phase trial focuses on Persistent Asthma and remains completed. Sponsored by AstraZeneca, it has been updated 7 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed

▶ Show 2 earlier versions

Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Mar 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

AstraZeneca

Data source: AstraZeneca

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Abbaretz, France , Abbeville, France , Achenheim, France , Achicourt, France , Afa, France , Aiguillon, France , Aixe-sur-Vienne, France , Ajaccio, France , Albertville, France , Albi, France and 714 more locations